当前位置:首页 - 行情中心 - 方盛制药(603998) - 财务分析

方盛制药

(603998)

  

流通市值:44.74亿  总市值:44.74亿
流通股本:4.39亿   总股本:4.39亿

方盛制药(603998)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润2.27亿元,每股收益0.53元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益171136.74万元,未分配利润83447.47万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产328616.51万元,负债157479.77万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入1,347,963,171.04910,248,983.06438,354,992.771,628,542,252.04
营业总成本1,150,514,693.55772,539,394.29376,020,762.611,474,391,400.57
营业利润249,015,829.13154,800,062.0679,004,804.68196,445,611.18
利润总额249,980,029.93155,200,561.1978,990,611.87203,338,297.11
净利润227,396,741.19135,639,638.368,264,902.22179,623,902.46
其他综合收益----
综合收益总额227,396,741.19135,639,638.368,264,902.22179,623,902.46
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计1,044,743,627.411,029,934,537.281,040,737,121.39920,669,331.89
非流动资产合计2,241,421,440.82,197,163,001.232,213,090,976.372,160,316,337.47
资产总计3,286,165,068.213,227,097,538.513,253,828,097.763,080,985,669.36
流动负债合计1,394,894,580.91,387,716,565.491,223,063,954.651,248,089,199.52
非流动负债合计179,903,075.33212,912,591.93372,403,462.06244,170,485.18
负债合计1,574,797,656.231,600,629,157.421,595,467,416.711,492,259,684.7
归属于母公司股东权益合计1,595,047,837.871,511,452,080.861,531,765,308.651,458,093,676.18
股东权益合计1,711,367,411.991,626,468,381.091,658,360,681.061,588,725,984.66
负债和股东权益合计3,286,165,068.213,227,097,538.513,253,828,097.763,080,985,669.36
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计1,355,541,917.05904,070,840.19428,136,924.21,741,191,132.88
经营活动现金流出小计1,238,554,589.24837,731,299.45381,238,666.061,653,653,190.08
经营活动产生的现金流量净额116,987,327.8166,339,540.7446,898,258.1487,537,942.8
投资活动现金流入小计113,435,934.3175,681,996.5433,209,624.69173,786,909.3
投资活动现金流出小计151,157,951.56116,817,135.9461,857,335.88371,189,378.72
投资活动产生的现金流量净额-37,722,017.25-41,135,139.4-28,647,711.19-197,402,469.42
筹资活动现金流入小计622,164,583.33549,324,583.33317,620,000521,881,950
筹资活动现金流出小计704,629,449.08574,681,992.98268,076,147.74613,429,268.39
筹资活动产生的现金流量净额-82,464,865.75-25,357,409.6549,543,852.26-91,547,318.39
汇率变动对现金及现金等价物的影响0.872.54-1.88
现金及现金等价物净增加额-3,199,554.32-153,005.7767,794,399.21-201,411,843.13
期末现金及现金等价物余额178,831,495.71181,878,044.26249,825,449.24182,031,050.03
TOP↑